2014, Número 3
<< Anterior Siguiente >>
Ann Hepatol 2014; 13 (3)
Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease
Beaton MD, Chakrabarti S, Adams PC
Idioma: Ingles.
Referencias bibliográficas: 6
Paginas: 353-356
Archivo PDF: 123.01 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Chandok N, Minuk G, Wengiel M, Uhanova J. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease. J Gastrointestin Liver Dis 2012; 21: 53-8.
Beaton M, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P. Phase II Clinical Trial of phlebotomy therapy for non-alcoholic liver disease. Aliment Pharmacol Ther 2013; 37: 720-9.
Crook MA. Hyperferritinaemia; laboratory implications. Ann Clin Biochem 2012; 49: 211-3.
Chandok N, Minuk G, Wengiel M, Uhanova J. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease. J Gastrointestin Liver Dis 2012; 21: 53-8.
Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.
Adams PC, Powell LW, Halliday JW. Isolation of a human hepatic ferritin receptor. Hepatology 1988; 8: 719-21.